Cytek Biosciences Inc (CTKB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,651 | -11,195 | -6,807 | 2,484 | -1,234 |
| Depreciation Amortization | 6,805 | 4,246 | 1,801 | 5,659 | 3,795 |
| Accounts receivable | -7,595 | -745 | 6,055 | -19,744 | -11,780 |
| Accounts payable and accrued liabilities | 10 | -1,699 | 305 | 1,862 | 2,770 |
| Other Working Capital | -6,670 | -1,401 | 3,693 | -39,928 | -35,188 |
| Other Operating Activity | 20,870 | 10,802 | -2,189 | 37,436 | 23,213 |
| Operating Cash Flow | $-4,231 | $8 | $2,858 | $-12,231 | $-18,424 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -74,563 | -119,081 | -123,239 | -44,454 | 0 |
| PPE Investments | -3,148 | -1,818 | -505 | -9,748 | -3,218 |
| Net Acquisitions | -44,896 | -44,895 | -44,895 | N/A | N/A |
| Purchase Of Investment | -235 | -235 | -235 | -1,587 | -1,587 |
| Purchase Sale Intangibles | -118 | -55 | N/A | -120 | -40 |
| Other Investing Activity | -118 | -55 | 0 | -120 | -40 |
| Investing Cash Flow | $-122,960 | $-166,084 | $-168,874 | $-55,909 | $-4,845 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,983 | N/A |
| Debt Repayment | -425 | -287 | -146 | -50 | N/A |
| Common Stock Issued | 1,127 | 686 | 203 | 1,204 | 1,036 |
| Common Stock Repurchased | -8,443 | -15 | N/A | 1,585 | 765 |
| Other Financing Activity | -317 | -168 | -57 | -209 | -138 |
| Financing Cash Flow | $-8,058 | $216 | $0 | $5,513 | $1,663 |
| Exchange Rate Effect | -622 | -2,096 | -1,090 | -2,491 | -1,489 |
| Beginning Cash Position | 299,500 | 299,500 | 299,500 | 364,618 | 364,618 |
| End Cash Position | 163,629 | 131,544 | 132,394 | 299,500 | 341,523 |
| Net Cash Flow | $-135,871 | $-167,956 | $-167,106 | $-65,118 | $-23,095 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,231 | 8 | 2,858 | -12,231 | -18,424 |
| Capital Expenditure | -3,148 | -1,818 | -505 | -9,748 | -3,218 |
| Free Cash Flow | -7,379 | -1,810 | 2,353 | -21,979 | -21,642 |